 WON-SALEM, N.C., Nov. 11, 2022 GLOBE NEWSWIRE -- ProKidney Corp. Nasdaq: PROK ProKidney, a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease CKD, today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in the following upcoming investor conferences: 